| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |